Literature DB >> 16945332

Novel role of the RET finger protein in estrogen receptor-mediated transcription in MCF-7 cells.

Steven M Townson1, Kaiyan Kang, Adrian V Lee, Steffi Oesterreich.   

Abstract

The Scaffold attachment factor B1 (SAFB1) is an estrogen receptor (ESR1) repressor that has been proposed to inhibit breast tumorigenesis. To obtain insight into the functions of SAFB1 we utilized a yeast two-hybrid screen and identified the Ret finger protein (RFP) as interacting with the SAFB1 C-terminus. RFP is a member of the trimotif (TRIM) family of proteins, which we found widely expressed in a series of breast cancer cell lines. We confirmed the interaction between SAFB1 and RFP through in vitro (GST-pull-down) and in vivo (coimmunoprecipitations) assays. We hypothesized that SAFB1 functions as a scaffolding protein to recruit proteins such as RFP into proximity with ESR1. Consequently, we asked whether RFP would modulate ESR1 activity and we discovered that RFP was important for the ESR1-dependent expression of cyclin D1 (CCND1) and the progesterone receptor (PR), but not IRS1 or MYC. Although RFP did not interact with ESR1 directly, it does coimmunoprecipitate with ESR1, demonstrating that RFP is found within the same protein complex. Chromatin immunoprecipitation assays (ChIP) located RFP to the TFF1 promoter, a known ESR1-regulated gene. Taken together, our study provides further evidence that coactivation and corepression are integrally linked processes and that RFP is a component of an ESR1 regulatory complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945332      PMCID: PMC1950156          DOI: 10.1016/j.bbrc.2006.08.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  RFP is a DNA binding protein associated with the nuclear matrix.

Authors:  T Isomura; K Tamiya-Koizumi; M Suzuki; S Yoshida; M Taniguchi; M Matsuyama; T Ishigaki; S Sakuma; M Takahashi
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

Review 2.  Steroid receptors and cell cycle in normal mammary epithelium.

Authors:  Elizabeth Anderson; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

3.  Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells.

Authors:  S Oesterreich; A V Lee; T M Sullivan; S K Samuel; J R Davie; S A Fuqua
Journal:  J Cell Biochem       Date:  1997-11-01       Impact factor: 4.429

4.  B30.2-like domain proteins: update and new insights into a rapidly expanding family of proteins.

Authors:  J Henry; I H Mather; M F McDermott; P Pontarotti
Journal:  Mol Biol Evol       Date:  1998-12       Impact factor: 16.240

5.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  The RET finger protein interacts with the hinge region of SMC3.

Authors:  Chirag A Patel; Giancarlo Ghiselli
Journal:  Biochem Biophys Res Commun       Date:  2005-04-29       Impact factor: 3.575

Review 7.  Estrogen signaling: a subtle balance between ER alpha and ER beta.

Authors:  Jason Matthews; Jan-Ake Gustafsson
Journal:  Mol Interv       Date:  2003-08

8.  SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements.

Authors:  O Nayler; W Strätling; J P Bourquin; I Stagljar; L Lindemann; H Jasper; A M Hartmann; F O Fackelmayer; A Ullrich; S Stamm
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

9.  Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.

Authors:  T Cao; E Duprez; K L Borden; P S Freemont; L D Etkin
Journal:  J Cell Sci       Date:  1998-05       Impact factor: 5.285

10.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Authors:  V Cavaillès; S Dauvois; F L'Horset; G Lopez; S Hoare; P J Kushner; M G Parker
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  7 in total

1.  Ret finger protein inhibits muscle differentiation by modulating serum response factor and enhancer of polycomb1.

Authors:  H J Kee; J-R Kim; H Joung; N Choe; S E Lee; G H Eom; J C Kim; S H Geyer; M Jijiwa; T Kato; K Kawai; W J Weninger; S B Seo; K-I Nam; M H Jeong; M Takahashi; H Kook
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.

Authors:  V Bartella; P Rizza; I Barone; D Zito; F Giordano; C Giordano; S Catalano; L Mauro; D Sisci; M L Panno; S A W Fuqua; S Andò
Journal:  Breast Cancer Res Treat       Date:  2012-05-24       Impact factor: 4.872

3.  SUMO E3 ligase activity of TRIM proteins.

Authors:  Y Chu; X Yang
Journal:  Oncogene       Date:  2010-10-25       Impact factor: 9.867

4.  Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteins.

Authors:  Kelly J Higgins; Shengxi Liu; Maen Abdelrahim; Kathryn Vanderlaag; Xinyi Liu; Weston Porter; Richard Metz; Stephen Safe
Journal:  Mol Endocrinol       Date:  2007-11-15

5.  Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo.

Authors:  Yanyan Ma; Zengtao Wei; Robert C Bast; Zhanying Wang; Yan Li; Meng Gao; Yanping Liu; Xiaoyan Wang; Chun Guo; Lining Zhang; Xiaoyan Wang
Journal:  Lab Invest       Date:  2015-11-16       Impact factor: 5.662

6.  Identifying gene locus associations with promyelocytic leukemia nuclear bodies using immuno-TRAP.

Authors:  Reagan W Ching; Kashif Ahmed; Paul C Boutros; Linda Z Penn; David P Bazett-Jones
Journal:  J Cell Biol       Date:  2013-04-15       Impact factor: 10.539

7.  Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer.

Authors:  Wenjie Liu; Yi Cui; Wen Ren; Joseph Irudayaraj
Journal:  Clin Epigenetics       Date:  2019-01-30       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.